Compound Evidence File
#EC-2026-0574
Letrozole
Filed under Oral Tablets. The bureau holds 118 laboratory returns for this compound from 44 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
44 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 7 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 10.0 | 10.0 | 10.0 | 17 Dec 2024 | 17 Dec 2024 |
| HomopeptideCASE #VI-2026-0760 | A | 7 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 9.2 | 8.4 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 2 | 9.2 | 9.1 | 9.4 | 7 May 2025 | 20 May 2026 |
| Anlv BiotechnologyCASE #VI-2026-0110 | X | 1 | 9.2 | 9.2 | 9.2 | 9 Jun 2025 | 9 Jun 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 9.1 | 8.4 | 10.0 | 21 May 2026 | 21 May 2026 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 8.9 | 8.9 | 8.9 | 6 May 2025 | 6 May 2025 |
| BeiBangAnCASE #VI-2026-0899 | X | 3 | 8.8 | 8.5 | 9.2 | 3 Jun 2025 | 25 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 5 | 8.7 | 7.0 | 9.8 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.3 | 7.5 | 10.0 | 23 May 2026 | 23 May 2026 |
| ScienceCASE #VI-2026-0636 | X | 1 | 8.2 | 8.2 | 8.2 | 3 Jul 2025 | 3 Jul 2025 |
| Pharma Grade PeptidesCASE #VI-2026-0208 | X | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 | 14 Jan 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 7 | 8.0 | 6.9 | 8.4 | 23 May 2026 | 23 May 2026 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 8.0 | 8.0 | 8.0 | 6 May 2025 | 6 May 2025 |
| Verified PeptidesCASE #VI-2026-0407 | X | 2 | 7.8 | 7.6 | 7.9 | 9 Jun 2025 | 21 May 2026 |
| Xingruida XDRCASE #VI-2026-0898 | X | 6 | 7.5 | 4.9 | 8.7 | 7 May 2025 | 25 May 2026 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 7.5 | 7.5 | 7.5 | 2 Jul 2025 | 2 Jul 2025 |
| Top PeptideCASE #VI-2026-0721 | X | 2 | 7.3 | 7.0 | 7.7 | 20 Jun 2025 | 25 May 2026 |
| InjectifyCASE #VI-2026-0387 | X | 2 | 7.3 | 5.0 | 9.7 | 24 Apr 2025 | 19 Jan 2026 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 6 | 7.0 | 5.8 | 8.9 | 9 Jun 2025 | 26 Jan 2026 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 6.9 | 6.9 | 6.9 | 13 Feb 2025 | 13 Feb 2025 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 1 | 6.8 | 6.8 | 6.8 | 17 Dec 2024 | 17 Dec 2024 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 6.7 | 6.7 | 6.7 | 24 Apr 2025 | 24 Apr 2025 |
| LiliPeptideCASE #VI-2026-0695 | X | 15 | 6.5 | 4.0 | 10.0 | 7 May 2025 | 19 Jan 2026 |
| Accelerate LabsCASE #VI-2026-0686 | X | 1 | 6.3 | 6.3 | 6.3 | 9 Jun 2025 | 9 Jun 2025 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 6.3 | 6.3 | 6.3 | 24 Apr 2025 | 24 Apr 2025 |
| Peptide CraftersCASE #VI-2026-0994 | X | 3 | 6.2 | 3.9 | 7.6 | 28 Mar 2025 | 20 May 2026 |
| Biolongevity LabsCASE #VI-2026-0442 | X | 2 | 5.9 | 5.6 | 6.3 | 8 Jul 2025 | 23 May 2026 |
| Zhejiang Yichenkang BiotechnologyCASE #VI-2026-0269 | X | 3 | 5.8 | 4.1 | 6.8 | 16 Mar 2025 | 20 May 2026 |
| Elite Research USACASE #VI-2026-0267 | X | 1 | 5.5 | 5.5 | 5.5 | 13 Feb 2025 | 13 Feb 2025 |
| LSPLCASE #VI-2026-0523 | X | 4 | 5.1 | 3.6 | 6.7 | 8 Jul 2025 | 24 May 2026 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 1 | 5.0 | 5.0 | 5.0 | 2 Jul 2025 | 2 Jul 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 4.8 | 4.8 | 4.8 | 3 Jun 2025 | 3 Jun 2025 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 4.7 | 4.7 | 4.7 | 28 Mar 2025 | 28 Mar 2025 |
| Oasis PeptidesCASE #VI-2026-0404 | X | 1 | 4.7 | 4.7 | 4.7 | 14 Jan 2025 | 14 Jan 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 3.8 | 3.8 | 3.8 | 9 Jun 2025 | 9 Jun 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 3.7 | 3.7 | 3.7 | 13 Jun 2025 | 13 Jun 2025 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 3.2 | 3.2 | 3.2 | 21 May 2025 | 21 May 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 3.2 | 3.2 | 3.2 | 3 Jul 2025 | 3 Jul 2025 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 1.9 | 1.9 | 1.9 | 2 Apr 2025 | 2 Apr 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.4 | 0.4 | 0.4 | 25 Apr 2025 | 25 Apr 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 13 Jun 2025 | 13 Jun 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.0 | 0.0 | 0.0 | 16 Mar 2025 | 16 Mar 2025 |
Open any subject to view the batch-level evidence for Letrozole alone.